<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04952298</url>
  </required_header>
  <id_info>
    <org_study_id>EASINESS</org_study_id>
    <nct_id>NCT04952298</nct_id>
  </id_info>
  <brief_title>EASINESS-TRIAL - Enhancing Safety in Epilepsy Surgery</brief_title>
  <official_title>EASINESS-TRIAL - An Analysis of Standardized Outcome References From an International Multicentre Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Erlangen-Nürnberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Clinic Frankfurt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vienna General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To conduct a retrospective multicenter cohort study to define surgical benchmark values for&#xD;
      best achievable outcomes following surgery for mesial temporal lobe epilepsy. Established&#xD;
      benchmark serve as reference values for the evaluation of future surgical strategies and&#xD;
      approaches.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgeons strive for the best possible outcome of their surgeries with the greatest possible&#xD;
      chance for recovery of the patients. Therefore, monitoring and quality improvement is&#xD;
      increasingly important in surgery. For this purpose, different concepts were developed with&#xD;
      the aim to assess best achievable results for several surgical procedures and reduce&#xD;
      unwarranted variation between different centers. The most common used concept in surgery is a&#xD;
      combination of various clinical indicators with a focus on treatment and adverse events which&#xD;
      offers a more reliable analysis than single-outcome indicators. The concept of a benchmark&#xD;
      establishes reference values which represents the best possible outcome of high-volume&#xD;
      centers and can be used for comparison and improvement. Benchmark values are established&#xD;
      within a patients' cohort for which the best possible outcome can be expected. The aim of our&#xD;
      study is the establishment of robust and standardized outcome references after&#xD;
      amygdalohippocampectomy for temporal lobe epilepsy. After successful implantation of&#xD;
      benchmarks from an international cohort of renowned centers, these data serve as reference&#xD;
      values for the evaluation of novel surgical techniques and comparisons among centers or&#xD;
      future clinical trials.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Seizure Outcome</measure>
    <time_frame>up to 1 year</time_frame>
    <description>International League Against Epilepsy (ILAE) Outcome Scale&#xD;
- Class 1 (seizure-free) to class 6 (&gt;100% increase of baseline seizure days)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Figural memory</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Improvement, unchanged, deterioration, e.g. at the Rey Auditory-Verbal Learning Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attention</measure>
    <time_frame>up to 1-year</time_frame>
    <description>Improvement, unchanged, deterioration, e.g. at the Wechsler Memory Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Verbal memory</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Improvement, unchanged, deterioration, e.g. at the Rey Auditory-Verbal Learning Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurological deficit</measure>
    <time_frame>up to 1 year</time_frame>
    <description>None, visual field loss, diplopia, motor deficit, sensory deficit, language impairment (according to NANO scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D-Volumetry of extent of resection on MRI</measure>
    <time_frame>3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of anticonvulsive drugs</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reoperation</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Temporalis muscle atrophy</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Not-visible or visible</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication of any severity</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>In-hospital mortality after index surgery</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of ICU stay after index surgery</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of stay after index surgery</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Age</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Sex</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Education status</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>American Society of Anaesthesiologists (ASA) physical status</measure>
    <time_frame>At time of surgery</time_frame>
    <description>1 (healthy person) to 6 (declared brain-dead person)</description>
  </other_outcome>
  <other_outcome>
    <measure>Body mass index</measure>
    <time_frame>At time of surgery</time_frame>
    <description>in kg/m^2</description>
  </other_outcome>
  <other_outcome>
    <measure>History of neonatal seizures</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>History of febrile seizures</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>History of encephalitis or meningitis</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Congestive heart failure</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Coagulopathy / bleeding disorder</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes mellitus</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Age at epilepsy onset</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Type of seizures</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Average monthly frequency of seizures impairing awareness in year before surgery</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of anticonvulsive drugs</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Neurological deficit</measure>
    <time_frame>At time of surgery</time_frame>
    <description>None, visual field loss, diplopia, motor deficit, sensory deficit, language impairment (according to NANO scale)</description>
  </other_outcome>
  <other_outcome>
    <measure>Preoperative MRI lesion</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>MRI post-processing conducted</measure>
    <time_frame>At time of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Additional preoperative diagnostic tool</measure>
    <time_frame>At time of surgery</time_frame>
    <description>PET, SPECT, MEG, Wada test</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of surgery</measure>
    <time_frame>Surgery</time_frame>
    <description>Selective amygdalohippocampectomy, anteromedial temporal lobe resection including amydalohippocampectomy, anterior temporal lobe resection</description>
  </other_outcome>
  <other_outcome>
    <measure>Intraoperative navigation</measure>
    <time_frame>Surgery</time_frame>
    <description>No or yes</description>
  </other_outcome>
  <other_outcome>
    <measure>Side of procedure</measure>
    <time_frame>Surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Operating duration</measure>
    <time_frame>Surgery</time_frame>
    <description>minutes</description>
  </other_outcome>
  <other_outcome>
    <measure>Histological finding</measure>
    <time_frame>At time of surgery</time_frame>
    <description>Hippocampal sclerosis, focal cortical dysplasia, dysembryoplastic neuroepithelial tumours, Ganglioglioma, others</description>
  </other_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Epilepsy, Temporal Lobe</condition>
  <condition>Amygdalo-Hippocampal Epilepsy</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mesial temporal lobe epilepsy surgery</intervention_name>
    <description>Medial temporal lobe epilepsy surgery including&#xD;
selective Amygdalohippocempectomy (SAH) including anterior parahippocampal gyrus / entorhinal cortex&#xD;
anteromedial temporal lobe resection including amygdalohippocampectomy&#xD;
anterior temporal lobe resection</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who went through medial temporal lobe epilepsy surgery at high-volume centres&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Centres with ≥30 seizure-specific resections (excluding vagus nerve stimulation) as an&#xD;
             average per year during the 5-year study period&#xD;
&#xD;
          -  Patients who went through mesial temporal lobe epilepsy surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Only neocortical temporal resection&#xD;
&#xD;
          -  Recurrent resection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Drexler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Drexler, MD</last_name>
    <phone>+4915222816461</phone>
    <email>r.drexler@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Sauvigny, MD</last_name>
    <email>t.sauvigny@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medical Center Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Drexler, MD</last_name>
      <phone>+4915222816461</phone>
      <email>r.drexler@uke.de</email>
    </contact>
    <investigator>
      <last_name>Richard Drexler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>June 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>June 26, 2021</last_update_submitted>
  <last_update_submitted_qc>June 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Richard Drexler</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Epilepsy, Temporal Lobe</mesh_term>
    <mesh_term>Epilepsies, Partial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

